Although Prozac was a huge success and produced billions of dollars in sales, Prozacs patent was due to legislate in 2003, deviation a few years to research and develop a subsequent product to take the reins as the companys flagship product. Pharmaceutical company Eli Lilly produced drugs that treated depression. Prozac was the industry attractor in the most popular class of medications: the selective serotonin reuptake inhibitors (SSRIs) (Ofek & Laufer, 2008, p. 1).
Prozacs patent was due to expire in a few short years and would line of business the company to stiff competition from generic competitors. As a result of this revelation Lilly was under the gun to develop a successor to Prozac to address the reduction of sales and tax from its flagship product Prozac. To further compound the problem a do of new depression-related drugs were introduced in the 1990s. Zoloft, Celexa, and Paxil were a succession of genuinely successful SSRI medications as a result of quail at marketing campaigns.
According to Okek and Laufer (2008) Eli Lilly addressed this issue by creating the unfermented Antidepressant Team (NAT), a cross-functional team of Lilly research and study and marketing that was formed to devise a successor schema for Prozac (p....If you want to get a full essay, sanctify it on our website: Orderessay
If you want to get a full essay, wisit our page: write my essay .
No comments:
Post a Comment